Universe Pharmaceuticals INC Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Universe Pharmaceuticals INC (UPC) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$85.44 million for the 12-month period ending 2025-09-30, per its 20-F filed 2026-01-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-01-29
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month as first filed |
|---|---|---|---|
| 2025-09-30 | -$85.44M 20-F · filed 2026-01-29 | ||
| 2024-09-30 | -$31.47M 20-F · filed 2026-01-29 | -$1.17M 20-F · filed 2025-04-29 | |
| 2024-03-31 | -$14.12K 6-K · filed 2024-09-20 | ||
| 2023-09-30 | $170.05M 20-F · filed 2026-01-29 | $244.01K 20-F · filed 2024-01-30 | |
| 2023-03-31 | -$465.43K 6-K · filed 2024-09-20 | ||
| 2022-09-30 | $2.32M 20-F · filed 2025-04-29 | ||
| 2022-03-31 | $727.51K 6-K · filed 2023-08-31 | ||
| 2021-09-30 | $31.44K 20-F · filed 2024-01-30 | ||
| 2021-03-31 | $305.09K 6-K · filed 2022-08-16 | ||
| 2020-09-30 | -$30.41K 20-F · filed 2023-02-10 | ||
| 2019-09-30 | $162.54K 20-F · filed 2022-01-31 |